We investigated the association of vitamin K status with warfarin sensitivi
ty among 40 orthopaedic patients beginning perioperative algorithm-dosed wa
rfarin. [Baseline vitamin K status was assessed using plasma vitamin K-1 an
d vitamin K-1 2.3 epoxide concentrations, and a questionnaire-based estimat
ion of usual vitamin K intake. Warfarin sensitivity was assessed as the inc
rease in the International Normalized Ratio (INR) after two doses of 5 mg o
f warfarin and as the 4-d accumulation of under-gamma -carboxylated prothro
mbin (PIVKA-II). adjusted for warfarin dose requirement. Multivariate model
s were used to assess vitamin K variables as predictors of warfarin sensiti
vity The mean INR increase was 0.53 U and the mean PIVKA-II increase was 77
1 ng/ml/mg warfarin. Demographic factors were not associated with warfarin
response. For each 1 standard deviation (SD) lower value of plasma vitamin
K-1, but not the other vitamin K variables, the INR rose 0.24 U (P less tha
n or equal to 0.01). A higher usual vitamin K intake and plasma vitamin K-1
, and lower plasma vitamin K-1 2.3 epoxide, were all associated with a lowe
r PIVKA-II increase over 4 d, Respective differences in PIVKA-II accumulati
on per SD increase of each variable were -165, -218 and 236 ngl ml/mg warfa
rin (all P less than or equal to 0.05). We concluded that dietary and bioch
emical measures of vitamin K status were associated with early warfarin sen
sitivity.